HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
Journal Article (Journal Article)
A paradigm shifting study demonstrated that induction of MHC class E and II-restricted CD8+ T cells was associated with the clearance of SIV infection in rhesus macaques. Another recent study highlighted the presence of HIV-1-specific class II-restricted CD8+ T cells in HIV-1 patients who naturally control infection (virus controllers; VCs). However, questions regarding class II-restricted CD8+ T cells ontogeny, distribution across different HIV-1 disease states and their role in viral control remain unclear. In this study, we investigated the distribution and anti-viral properties of HLA-DRB1*0701 and DQB1*0501 class II-restricted CD8+ T cells in different HIV-1 patient cohorts; and whether class II-restricted CD8+ T cells represent a unique T cell subset. We show that memory class II-restricted CD8+ T cell responses were more often detectable in VCs than in chronically infected patients, but not in healthy seronegative donors. We also demonstrate that VC CD8+ T cells inhibit virus replication in both a class I- and class II-dependent manner, and that in two VC patients the class II-restricted CD8+ T cells with an anti-viral gene signature expressed both CD4+ and CD8+ T cell lineage-specific genes. These data demonstrated that anti-viral memory class II-restricted CD8+ T cells with hybrid CD4+ and CD8+ features are present during natural HIV-1 infection.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
- Ferrari, Guido
- Freel, Stephanie
- Haynes, Barton Ford
- Li, Qi-Jing
- Moody, Michael Anthony
- Tomaras, Georgia Doris
- Weinhold, Kent James
- Wiehe, Kevin J
Cited Authors
- Nyanhete, TE; Frisbee, AL; Bradley, T; Faison, WJ; Robins, E; Payne, T; Freel, SA; Sawant, S; Weinhold, KJ; Wiehe, K; Haynes, BF; Ferrari, G; Li, Q-J; Moody, MA; Tomaras, GD
Published Date
- July 15, 2019
Published In
Volume / Issue
- 9 / 1
Start / End Page
- 10165 -
PubMed ID
- 31308388
Pubmed Central ID
- PMC6629643
Electronic International Standard Serial Number (EISSN)
- 2045-2322
Digital Object Identifier (DOI)
- 10.1038/s41598-019-46462-8
Language
- eng
Conference Location
- England